They're seeking anti-trust approvals.
(Press Release) MILAN, ITALY, and CHARENTON-LE-PONT, FRANCE – The proposed combination between
Essilor (Euronext Paris: EI) and Luxottica (MTA: LUX) continues to progress, with the antitrust process advancing in all jurisdictions.
Essilor and Luxottica have jointly filed with the antitrust authorities in three of the five jurisdictions whose approvals are a condition precedent to the closing of the transaction, namely the U.S., Canada and Brazil.
In the U.S. and Canada, the investigation has entered the phase of a secondary request, as expected for such a sizeable deal.
In China, the fourth jurisdiction for which approval is a condition precedent, the proposed transaction is under MOFCOM’s review and notification acceptance is expected shortly.
In Europe, the fifth jurisdiction for which approval is a condition precedent, the two companies are conducting an open and constructive dialogue with the Commission in the context of the pre-notification phase and expect to be able to formally notify the transaction in the coming weeks.
The two companies have already received clearance in Russia and India. In other relevant jurisdictions, the two companies have notified the transaction and are conducting an open and constructive dialogue with the antitrust authorities.
The two companies’ shared objective in cooperation with the relevant authorities is to close the antitrust process around the end of the year.
Hear What the Industry Thinks About the Ultimate Lens Package by Essilor
Eye care professionals, patients, and Essilor sales consultants shared their feedback on the Ultimate Lens Package. Watch to see why they believe the innovation behind the lens can make the difference for your practice and for your patients. For more information on the Ultimate Lens Package, contact an Essilor Sales Consultant or click here.